Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Pharm Biol ; 62(1): 2294331, 2024 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-38126136

RESUMEN

CONTEXT: Coix [Coix lacryma-jobi L. var. mayuen (Roman.) Stapf (Poaceae)], a crop of medicinal and edible significance, contains coixol, which has demonstrated anticancer properties. However, the limited solubility of coixol restricts its potential therapeutic applications. OBJECTIVE: This study prepared a water-soluble coixol-ß-cyclodextrin polymer (CDP) inclusion compound and evaluated its anticancer effect. MATERIALS AND METHODS: The coixol-CDP compound was synthesized through a solvent-stirring and freeze-drying technique. Its coixol content was quantified using HPLC, and its stability was tested under various conditions. The anticancer effects of the coixol-CDP compound (4.129, 8.259, 16.518, and 33.035 mg/L for 24, 48, and 72 h) on the proliferation of non-small cell lung cancer (NSCLC) A549 cells were evaluated using an MTT assay; cell morphology was examined by Hoechst nuclear staining; apoptosis and cell cycle was detected by flow cytometry; and the expression of apoptosis-related proteins was assessed by Western blots. RESULTS: The water-soluble coixol-CDP inclusion compound was successfully prepared with an inclusion ratio of 86.6% and an inclusion yield rate of 84.1%. The coixol content of the compound was 5.63% and the compound remained stable under various conditions. Compared to coixol alone, all 24, 48, and 72 h administrations with the coixol-CDP compound exhibited lower IC50 values (33.93 ± 2.28, 16.80 ± 1.46, and 6.93 ± 0.83 mg/L) in A549 cells; the compound also showed stronger regulatory effects on apoptosis-related proteins. DISCUSSION AND CONCLUSIONS: These findings offer a new perspective for the potential clinical application of Coix in NSCLC therapy and its future research.


Asunto(s)
Carcinoma de Pulmón de Células no Pequeñas , Coix , Neoplasias Pulmonares , beta-Ciclodextrinas , Humanos , Carcinoma de Pulmón de Células no Pequeñas/tratamiento farmacológico , Polímeros/farmacología , Neoplasias Pulmonares/tratamiento farmacológico , beta-Ciclodextrinas/farmacología , Agua
2.
PeerJ ; 12: e17163, 2024.
Artículo en Inglés | MEDLINE | ID: mdl-38766480

RESUMEN

Background: The evidence on the effects of extreme meteorological conditions and high air pollution levels on incidence of hand, foot and mouth disease (HFMD) is limited. Moreover, results of the available studies are inconsistent. Further investigations are imperative to elucidate the specific issue. Methods: Data on the daily cases of HFMD, meteorological factors and air pollution were obtained from 2017 to 2022 in Jining City. We employed distributed lag nonlinear model (DLNM) incorporated with Poisson regression to explore the impacts of extreme meteorological conditions and air pollution on HFMD incidence. Results: We found that there were nonlinear relationships between temperature, wind speed, PM2.5, SO2, O3 and HFMD. The cumulative risk of extreme high temperature was higher at the 95th percentile (P95th) than at the 90th percentile(P90th), and the RR values for both reached their maximum at 10-day lag (P95th RR = 1.880 (1.261-2.804), P90th RR = 1.787 (1.244-2.569)), the hazardous effect of extreme low temperatures on HFMD is faster than that of extreme high temperatures. The cumulative effect of extreme low wind speeds reached its maximum at 14-day lag (P95th RR = 1.702 (1.389-2.085), P90th RR = 1.498(1.283-1.750)). The cumulative effect of PM2.5 concentration at the P90th was largest at 14-day lag (RR = 1.637 (1.069-2.506)), and the cumulative effect at the P95th was largest at 10-day lag (RR = 1.569 (1.021-2.411)). High SO2 concentration at the P95th at 14-day lag was associated with higher risk for HFMD (RR: 1.425 (1.001-2.030)). Conclusion: Our findings suggest that high temperature, low wind speed, and high concentrations of PM2.5 and SO2 are associated with an increased risk of HFMD. This study not only adds insights to the understanding of the impact of extreme meteorological conditions and high levels of air pollutants on HFMD incidence but also holds practical significance for the development and enhancement of an early warning system for HFMD.


Asunto(s)
Contaminantes Atmosféricos , Contaminación del Aire , Enfermedad de Boca, Mano y Pie , Enfermedad de Boca, Mano y Pie/epidemiología , China/epidemiología , Humanos , Incidencia , Contaminantes Atmosféricos/efectos adversos , Contaminantes Atmosféricos/análisis , Contaminación del Aire/efectos adversos , Contaminación del Aire/análisis , Material Particulado/efectos adversos , Material Particulado/análisis , Preescolar , Femenino , Viento , Masculino , Lactante , Dióxido de Azufre/análisis , Dióxido de Azufre/efectos adversos , Conceptos Meteorológicos , Clima Extremo , Niño
3.
J Chromatogr A ; 1632: 461607, 2020 Nov 22.
Artículo en Inglés | MEDLINE | ID: mdl-33080535

RESUMEN

There is an urgent need for developing advanced purification techniques with the merits of low cost and satisfactory capacity in order to meet the challenges in the current downstream purification of monoclonal antibodies (mAbs). Herein, a simple and inexpensive nitrogen heterocycle molecule, 1-vinylimidazole (VIM), was proposed as the capture ligand of antibodies for the first time. The corresponding VIM-based non-affinity polymeric material (polyVIM) was then fabricated via a one-step polymerization for use in the highly selective purification of antibodies. Compared to the previously reported materials, this novel material exhibited many advantages without clearly sacrificing selectivity, such as a simpler and faster fabrication (within 1.5 h), comparable or even higher binding capacity (saturated static adsorption capacity > 190 mg/g polymer, dynamic binding capacity about 31.62 mg/g polymer), lower non-specific protein adsorption, and much lower cost. Notably, the polyVIM can effectively purify the antibodies from multiple biological sources with high purity (95.4% for mAbs in the cell culture medium, 93.3% for hIgG in the human serum), with an acceptable recovery (91.6% for mAbs, 77.0% for hIgG), and good reusability (> 10 times). Moreover, the target ELISA binding assay and NFAT-luc reporter gene assay demonstrated that the enriched antibodies can well maintain their binding activity and bioactivity during the whole purification process. The excellent performance of the polyVIM material may be attributed to the high recognition ability of VIM for antibodies, as well as the biocompatible and antifouling properties of the porous polymer. This study provides a promising alternative material for the purification of mAbs in downstream processes and the enrichment of hIgG in human serum.


Asunto(s)
Anticuerpos Monoclonales/aislamiento & purificación , Imidazoles/química , Polímeros/química , Adsorción , Animales , Bevacizumab/aislamiento & purificación , Células CHO , Calorimetría , Cricetinae , Cricetulus , Humanos , Inmunoglobulina G/sangre , Ligandos , Ratones , Espectroscopía Infrarroja por Transformada de Fourier
4.
Sichuan Da Xue Xue Bao Yi Xue Ban ; 37(2): 180-2, 2006 Mar.
Artículo en Zh | MEDLINE | ID: mdl-16608069

RESUMEN

OBJECTIVE: To elucidate the biofilm structure of Actinomyces viscosus and the spatial distribution of exopolysaccharides in it. METHODS: The Actinomyces viscosus biofilm was made by allowing bacteria to attach to the cover glass surface. The biofilm structure and exopolysaccharides distribution at 24 hours were stained with Fluorescein, BODIPY and Calcofluor respectively and were visualized by confocal laser scanning microscopy (CLSM). RESULTS: Actinomyces viscosus could attach to glass surface and form a structural biofilm where bacteria were embedded in the EPS glycocalyx polymers, and characteristic microcolonies and channels were taking shape. Bacteria were sparse in the substratum area but crowd in the center. In the biofilm, the distribution of bacteria was consistent with the distribution of exopolysaccharides. CONCLUSION: The findings demonstrate an important role of exopolysaccharides in the process of Actinomyces viscosus biofilm formation.


Asunto(s)
Actinomyces viscosus/fisiología , Biopelículas , Polisacáridos Bacterianos/fisiología , Adhesión Bacteriana , Placa Dental , Humanos , Microscopía Confocal , Polisacáridos Bacterianos/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA